• Two dosing regimens (day before, split-dose)1,2
  • High success rates* in both dosing regimens1,2
  • Less prep time compared to HalfLytely1
  • Safety and tolerability similar to other bowel preps1,2

References: 1. Data on file. Braintree Laboratories, Inc., Braintree, MA. 2. Suclear [package insert]. Braintree, MA; Braintree Laboratories, Inc; 2013. *Based on investigator grading.

Suclear® (sodium sulfate, potassium sulfate and magnesium sulfate oral solution; and PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution) is a combination of osmotic laxatives indicated for cleansing of the colon as a preparation for colonoscopy in adults. Most common adverse reactions (>2%) are overall discomfort, abdominal distention, abdominal pain, nausea, vomiting and headache. Use is contraindicated in the following conditions: gastrointestinal (GI) obstruction, bowel perforation, toxic colitis and toxic megacolon, gastric retention, ileus, known allergies to components of Suclear. Use caution when prescribing for patients with a history of seizures, arrhythmias, impaired gag reflex, regurgitation or aspiration, impaired renal function or patients taking medications that may affect renal function or electrolytes. Patients with severe active ulcerative colitis may be at increased risk of exacerbation of their disease. Administration of osmotic laxative products may produce mucosal aphthous ulcerations, and there have been reports of more serious cases of ischemic colitis requiring hospitalization. Patients with impaired water handling who experience severe vomiting should be closely monitored including measurement of electrolytes. Advise all patients to hydrate adequately before, during, and after use. Each bottle must be diluted with water to the recommended final volume.

Click here for Full Prescribing Information and Medication Guide

Braintree Laboratories Code of Conduct
Braintree Laboratories California Health and Safety Code Statement

© 2016 Braintree Laboratories, Inc.